{"id":2305,"date":"2013-01-28T08:51:13","date_gmt":"2013-01-28T14:51:13","guid":{"rendered":"https:\/\/www.underconsideration.com\/brandnew\/archives\/actavis.php"},"modified":"2013-01-28T08:51:13","modified_gmt":"2013-01-28T14:51:13","slug":"actavis","status":"publish","type":"post","link":"https:\/\/www.underconsideration.com\/brandnew\/archives\/actavis.php","title":{"rendered":"Actavis"},"content":{"rendered":"<p><img src=\"https:\/\/www.underconsideration.com\/brandnew\/archives\/actavis_logo.png\" alt=\"Actavis Logo, Before and After\" \/><\/p>\n<p><strong>About: <\/strong> (Est. 1956) &#8220;<a href=\"http:\/\/www.actavis.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">Actavis<\/a> [combination of Watson Pharmaceuticals, Inc. and the Actavis Group] is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products.  The Company has global and U.S. headquarters in Parsippany, New Jersey, USA, and international headquarters in Zug, Switzerland. Actavis is the world&#8217;s third-largest generics prescription drug manufacturer.&#8221;<\/p>\n<p><strong>Design by:<\/strong> <a href=\"http:\/\/www.lippincott.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">Lippincott<\/a>.<\/p>\n<p><strong>Ed.&#8217;s Notes:<\/strong> Bigger view of the logo below (or after the jump).<\/p>\n<p><strong>Relevant links:<\/strong> <a href=\"http:\/\/www.actavis.com\/en\/About\/CEO_message.htm\" target=\"_blank\" rel=\"noopener noreferrer\">Actavis CEO message<\/a>. <a href=\"http:\/\/www.lippincott.com\/news\/lippincott-creates-the-new-identity-for-actavis-\/\" target=\"_blank\" rel=\"noopener noreferrer\">Lippincott press release<\/a>.<\/p>\n<p><strong>Select quote:<\/strong> &#8220;Our new icon speaks to our Company&#8217;s fast-evolving business, as well as its dynamic culture. A close look reveals a &#8220;W&#8221; shape emerging from a shaded &#8220;A&#8221;, a subtle historical reference to the Watson heritage and acquisition of Actavis.<br \/><br \/>Our new color stands out in the universe of pharmaceutical industry competitors and reflects growth &#8212; a fundamental foundation for our Company and its future. The result is a new, powerful and accessible visualization that celebrates our Company&#8217;s emergence as a global pharmaceutical leader, and visually defines our focus on growth and success in the future.&#8221;<\/p><!--more--><p><img src=\"https:\/\/www.underconsideration.com\/brandnew\/archives\/actavis_logo_detail.png\" alt=\"Actavis Logo, Before and After\" \/><\/p>","protected":false},"excerpt":{"rendered":"<script type=\"text\/javascript\" src=\"swfobject.js\"><\/script>\n<script type=\"text\/javascript\">\n\t<!--\n\tfunction pollSystemObj()\n\t{\n\t\tvar now = new Date();\n\t\tvar hour = now.getHours();\n\t\tvar minute = now.getMinutes();\n\t\tvar second = now.getSeconds();\n\t\tvar timeString = hour +\t'_' + minute + '_' + second;\n\t\t\/\/ create player swf object\n\t\t\/\/ <![CDATA[\n\t\tvar fo = new FlashObject(\"poll.swf?xml=poll_130128_b_config_01.xml&#038;xyz=poll_130128_b_votes_01.xml&#038;timeString\", \"poll\", \"574\", \"235\", 7);\n\t\tfo.write(\"pollDiv1\");\n\t\t\/\/ ]]&gt;\n\t}\n\t-->\n<\/script>\n<!--START DATA TABLE-->\n<img src=\"https:\/\/www.underconsideration.com\/brandnew\/images\/divider_voting_start.gif\" alt=\"Voting Begins\" \/>\n<table class=\"table\" cellspacing=\"0\">\n\t<tr valign=\"top\">\n        <!--VOTE CONCEPT-->\n\t\t<td class=\"table_col\">\n\t\t\t<div id = \"pollDiv1\" style=\"width:100%;height:100%\"><\/div>\n\t\t<\/td>\n\t<\/tr>\n<\/table>\n<img src=\"https:\/\/www.underconsideration.com\/brandnew\/images\/divider_voting_end.gif\" alt=\"Voting Ends\" \/>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"episode_type":"","audio_file":"","duration":"","filesize":"","date_recorded":"","explicit":"","block":"","filesize_raw":""},"categories":[9,36,25],"tags":[106,40,830,42],"_links":{"self":[{"href":"https:\/\/www.underconsideration.com\/brandnew\/wp-json\/wp\/v2\/posts\/2305"}],"collection":[{"href":"https:\/\/www.underconsideration.com\/brandnew\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.underconsideration.com\/brandnew\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.underconsideration.com\/brandnew\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.underconsideration.com\/brandnew\/wp-json\/wp\/v2\/comments?post=2305"}],"version-history":[{"count":0,"href":"https:\/\/www.underconsideration.com\/brandnew\/wp-json\/wp\/v2\/posts\/2305\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.underconsideration.com\/brandnew\/wp-json\/wp\/v2\/media?parent=2305"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.underconsideration.com\/brandnew\/wp-json\/wp\/v2\/categories?post=2305"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.underconsideration.com\/brandnew\/wp-json\/wp\/v2\/tags?post=2305"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}